NUMBER determination debrisoquine oxidation phenotype carried NUMBER healthy subjects NUMBER patients chronic bronchitis NUMBER patients lung cancer caucasian origin NUMBER distribution log ratio observed groups NUMBER assuming antimode NUMBER proportion pms NUMBER healthy subjects NUMBER chronic bronchitics NUMBER patients lung cancer differences significant NUMBER presence lung tumour influence phenotype group NUMBER patients phenotyped surgery NUMBER conclude link debrisoquine phenotype lung cancer unlikely non gaussian d hd